Autologous stem cell transplantation vs chemotherapy in adult acute lymphocytic leukaemia

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Naumann, Frauke ^a   Kruse, E ^b   Weingart, O ^b   Bohlius, J ^b   Hubel K ^b   Herrmann Frank, A ^b   Skipka, G ^b   Engert, A ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOCYTIC LEUKEMIA; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA EXTRACTION; DRUG EFFICACY; HUMAN; META ANALYSIS; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 44949180885     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006835     Document Type: Review

References (35)

1. Alvarnas 2004 Alvarnas JC, Forman SJ. Graft purging in autologous bone marrow transplantation: a promise not quite fulfilled. Oncology 2004;18(7):867-876.
2. Armstrong 2005 Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J. Clin. Oncol 2005;23(26):6306-6315.
3. Bhatia 2005 Bhatia S, Robison LL, Francisco L, Carter A, Liu Y, Grant M, Baker KS, Fung H, Gurney JG, McGlave PB, Nademanee A, Ramsay NK, Stein A, Weisdorf DJ, Forman SJ. Latemortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood 2005;105(11):4215-4222.
4. Bruggemann 2006 Bruggemann M, Raff T, Flohr T, Gokbuget N, Nakao M, Droese J, Luschen S, Pott C, Ritgen M, Scheuring U, Horst HA, Thiel E, Hoelzer D, Bartram CR, Kneba M. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood 2006;107(3):1116-1123.
5. Deangelo 2005 Deangelo DJ. The treatment of adolescents and young adults with acute lymphoblastic leukemia. Hematology 2005;(Am.Soc. Hematol.Educ.Program.):123-130.
6. Dhedin 2006 Dhedin N, Dombret H, Thomas X, Lheritier V, Boiron JM, Rigal-Huguet F, Vey N, Kuentz M, Reman O, Witz F, Delannoy A, Kovacsovics T, Bradstock K, Charrin C, Boucheix C, Gabert J, Blaise D, Fiere D, Vernant JP. Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials. Leukemia 2006;20(2):336-344.
7. Dombret 2002 Dombret H, Gabert J, Boiron JM, Rigal-Huguet F, Blaise D, Thomas X, Delannoy A, Buzyn A, Bilhou-Nabera C, Cayuela JM, Fenaux P, Bourhis JH, Fegueux N, Charrin C, Boucheix C, Lheritier V, Esperou H, Macintyre E, Vernant JP, Fiere D, Groupe d'Etude et de Traitement de la Leucemie Aigue Lymphoblastique de l'Adulte (GET-LALA Group). Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia - results of the prospective multicenter LALA-94 trial. Blood 2002;100(7):2357- 2366.
8. Egerer 2003 Egerer G, Goldschmidt H, Zoz M, Ho AD. Autologous bone marrow transplantation in adult patients with acute lymphoblastic leukemia. Leuk.Lymphoma 2003;44(1):9-14.
9. Egger 1997 Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-634.
10. Faderl 2003 Faderl S, Jeha S, Kantarjian HM. The biology and therapy of adult acute lymphoblastic leukemia. [Review] [201 refs]. Cancer 2003;98(7):1337-1354.
11. Fielding 2006 Fielding AK, Richards SM, Chopra R, Lazarus HM, Litzow M, Buck G, Durrant IJ, Luger SM, Marks DI, McMillan AK, Tallman MS, Rowe JM, Goldstone AH. Outcome of 609 adults after relapse of acute lymphoblastic leukaemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood 2006;Epub ahead of print:pp 200605018.
12. Fiere 1990 Fiere D, Broustet A, Leblond V, Maraninchi D, Castaigne S, Flesch M, Varet B, Vernant JP, Milpied N, Troussard X. Comparison of chemotherapy and autologous and allogeneic transplantation as postinduction regimen in adult acute lymphoblastic leukemia: a preliminary multicentric study. Haematology and blood transfusion 1990;33:409-412.
13. Fiere 1993 Fiere D, Lepage E, Sebban C, Boucheix C, Gisselbrecht C, Vernant JP, Varet B, Broustet A, Cahn JY, Rigal-Huguet F. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 1993;11(10):1990-2001.
14. Gokbuget 2000 Gokbuget N, Hoelzer D, Arnold R, Bohme A, Bartram CR, Freund M, Ganser A, Kneba M, Langer W, Lipp T, Ludwig WD, Maschmeyer G, Rieder H, Thiel E, Weiss A, Messerer D. Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol. Oncol. Clin. North Am 2000;14(6):1307-25, ix.
15. Granena 2003 Granena Batista A, Ferra CC. Autologous stem cell transplantation and purging in adult acute lymphoblastic leukaemia. [Review] [112 refs]. Bailliere's Best Practice in Clinical Haematology 2003;15(4):675-693.
16. Hahn 2006 Hahn T, Wall D, Camitta B, Davies S, Dillon H, Gaynon P, Larson RA, Parsons S, Seidenfeld J, Weisdorf D, McCarthy PL, Jr. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. Biol.Blood Marrow Transplant 2006;12(1):1-30.
17. Higgins 2006 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd, [updated September 2006].
18. Hoelzer 1988 Hoelzer D, Thiel E, Loffler H, Buchner T, Ganser A, Heil G, Koch P, Freund M, Diedrich H, Ruhl H. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988;71(1):123-31.
19. Hoelzer 2002 Hoelzer D, Gokbuget N, Ottmann O, Pui CH, Relling MV, Appelbaum FR, van Dongen JJ, Szczepanski T. Acute lymphoblastic leukemia. [Review] [211 refs]. Hematology 2002;:162-92, 2002.:-92.
20. Hopewell 2006 Hopewell S, Clarke M, Askie L. Reporting of trials presented in conference abstracts needs to be improved. Journal of Clinical Epidemiology 2006;59(7):681-684.
21. Juni 1999 Juni P, Witschi A, Bloch R, Egger M. The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis. JAMA: The Journal of the American Medical Association 1999;282(11):1054-1060.
22. Juni 2001 Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-46.
23. Labar 2004 Labar B, Suciu S, Zittoun R, Muus P, Marie JP, Fillet G, Peetermans M, Stryckmans P, Willemze R, Feremans W, Jaksic B, Bourhis J-H, Burghouts J-P, de WT. Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients >= 50 years old in first complete remission: Results of the EORTC ALL-3 trial. Haematologica 2004;89(7):809-817.
24. Larson 1995 Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood 1995;85(8):2025-2037.
25. Ljungman 2006 Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H, Gratwohl A, Madrigal A, Niederwieser D, Passweg J, Rocha V, Saccardi R, Schouten H, Schmitz N, Socie G, Sureda A, Apperley J. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2006;37(5):439-449.
26. Marks 2006 Marks DI, Aversa F, Lazarus HM. Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options. Bone Marrow Transplant 2006;38(7):467-475.
27. Mato 2006 Mato AR, Luger SM. Autologous stem cell transplant in ALL: who should we be transplanting in first remission?. Bone Marrow Transplant 2006;37(11):989-995.
28. Moher 2001 Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357(9263):1191-1194.
29. Ottmann 2005 Ottmann OG, Wassmann B. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Hematology 2005;Am.Soc.Hematol.Educ.Program.:118-122.
30. Raff 2006 Raff T, Gokbuget N, Luschen S, Reutzel R, Ritgen M, Irmer S, Bottcher S, Horst HA, Kneba M, Hoelzer D, Bruggemann M. Molecular relapse in adult standard risk ALL patients detected by prospective MRD-monitoring during and after maintenance treatment - data from the GMALL 06/99 and 07/03 trials. Blood 2006;0 Epub ahead of print:pp. 200607037.
31. Ribera 2005 Ribera JM, Oriol A, Bethencourt C, Parody R, Hernandez-Rivas JM, Moreno MJ, del Potro E, Torm M, Rivas C, Besalduch J, Sanz MA, Ortega JJ. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. Haematologica 2005;90(10):1346-1356.
32. Rowe 2005 Rowe JM, Buck G, Burnett AK, Chopra R, Wiernik PH, Richards SM, Lazarus HM, Franklin IM, Litzow MR, Ciobanu N, Prentice HG, Durrant J, Tallman MS, Goldstone AH, for ECOG and the MRC/NCRI Adult Leukemia Working Party. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood 2005;106(12):3760-3767.
33. Rowe 2006 Rowe JM, Buck G, Fielding A, Tallman M, Burnett AK, Chopra R, Wiernik PH, Richards SM, Lazarus HM, Foroni L, Paietta E, Litzow MR, Marks D, Durrant J, Goldstone AH. In adults with standard-risk acute lymphoblastic leukemia (ALL) the greatest benetif is achieved from an allogeneic transplant in first complete remission (CR) and an autologous transplant is less effective than conventional consolidation/maintenance chemotherapy: final results of the international ALL trial (MRCUKALL XII/ECOGE2993). Blood. 2006;Vol. 108, issue 11:5a.
34. Thiebaut 2000 Thiebaut A, Vernant JP, Degos L, Huguet FR, Reiffers J, Sebban C, Lepage E, Thomas X, Fiere D. Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87. [Review] [39 refs]. Hematology - Oncology Clinics of North America 2000;14(6):1353- 1366.
35. Thomas 2004 Thomas X, Boiron JM, Huguet F, Dombret H, Bradstock K, Vey N, Kovacsovics T, Delannoy A, Fegueux N, Fenaux P, Stamatoullas A, Vernant JP, Tournilhac O, Buzyn A, Reman O, Charrin C, Boucheix C, Gabert J, Lheritier V, Fiere D. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. Journal of Clinical Oncology 2004;22(20):4075-4086.